Civic Intelligence

International Partnership for Microbicides Inc

990 • Fiscal year 2019 • EIN 01-0741733

Jan 01, 2019 to Dec 31, 2019 • Filed on Sep 30, 2020

Organization ProfileWWW.IPMGLOBAL.ORG

View Organization Page

8405 COLESVILLE ROAD Suite 600Silver Spring, MD 20910

(301) 608-2221

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

75th percentile

0.56x

Higher debt load relative to assets than 75% of similar nonprofits.

2019 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2019

Liabilities / Revenue

68th percentile

0.62x

Higher debt load relative to revenue than 68% of similar nonprofits.

2019 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2019

Net Margin

45th percentile

1.9%

Higher net margin than 45% of similar nonprofits.

2019 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2019

Top Officer Pay

87th percentile

$605,884

Higher top officer pay than 87% of similar nonprofits.

Top officer pay equals 2.4% of source-year revenue.

2019 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2019

Asset Growth

75th percentile

13%

Faster asset growth than 75% of similar nonprofits.

2019 filings • 501(c)3 • $25M-$50M nonprofits • Annualized from 2018 to 2019

Revenue Growth

37th percentile

0.2%

Faster revenue growth than 37% of similar nonprofits.

2019 filings • 501(c)3 • $25M-$50M nonprofits • Annualized from 2018 to 2019

Balance Sheet
Liabilities / Assets75th percentile

Assets

Up

$28,113,782

Up $3,275,582 (+13%) from 2018

Net Assets

Up

$12,437,488

Up $403,062 (+3.3%) from 2018

Liabilities

Up

$15,676,294

Up $2,872,520 (+22%) from 2018

Revenue And Expenses
Liabilities / Revenue68th percentileNet Margin45th percentile

Revenue

Up

$25,249,274

Up $43,062 (+0.2%) from 2018

Expenses

Down

$24,773,576

Down $1,563,602 (-5.9%) from 2018

Net Income

Up

$475,698

Up $1,606,664 (+142%) from 2018

Historical Trend

Balance Sheet Trend

Asset Growth75th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100M$50M$0Assets 2010: $81,520,037Liabilities 2010: $58,213,017Net Assets 2010: $23,307,0202010Assets 2011: $52,600,905Liabilities 2011: $31,502,185Net Assets 2011: $21,098,7202011Assets 2012: $41,958,199Liabilities 2012: $22,695,453Net Assets 2012: $19,262,7462012Assets 2013: $40,537,408Liabilities 2013: $23,421,275Net Assets 2013: $17,116,1332013Assets 2014: $28,873,020Liabilities 2014: $14,087,446Net Assets 2014: $14,785,5742014Assets 2015: $23,222,913Liabilities 2015: $10,179,304Net Assets 2015: $13,043,6092015Assets 2016: $20,060,195Liabilities 2016: $5,525,129Net Assets 2016: $14,535,0662016Assets 2017: $23,049,272Liabilities 2017: $9,788,866Net Assets 2017: $13,260,4062017Assets 2018: $24,838,200Liabilities 2018: $12,803,774Net Assets 2018: $12,034,4262018Assets 2019: $28,113,782Liabilities 2019: $15,676,294Net Assets 2019: $12,437,4882019Assets 2020: $23,470,693Liabilities 2020: $11,916,324Net Assets 2020: $11,554,3692020Assets 2021: $16,214,079Liabilities 2021: $4,385,112Net Assets 2021: $11,828,9672021Assets 2022: $0Liabilities 2022: $0Net Assets 2022: $02022

Highlighted filing

2019

Assets$28,113,782
Liabilities$15,676,294
Net Assets$12,437,488
Open 2019 Filing

Operations Trend

Revenue Growth37th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$60M$40M$20M$0-$20MExpenses 2010: $56,341,7012010Expenses 2011: $37,733,2382011Revenue 2012: $31,674,981Expenses 2012: $31,029,986Net Income 2012: $644,9952012Revenue 2013: $32,787,591Expenses 2013: $33,447,172Net Income 2013: -$659,5812013Revenue 2014: $31,552,023Expenses 2014: $32,244,291Net Income 2014: -$692,2682014Revenue 2015: $33,000,728Expenses 2015: $33,224,496Net Income 2015: -$223,7682015Revenue 2016: $35,971,802Expenses 2016: $33,779,041Net Income 2016: $2,192,7612016Revenue 2017: $35,724,324Expenses 2017: $36,807,047Net Income 2017: -$1,082,7232017Revenue 2018: $25,206,212Expenses 2018: $26,337,178Net Income 2018: -$1,130,9662018Revenue 2019: $25,249,274Expenses 2019: $24,773,576Net Income 2019: $475,6982019Revenue 2020: $20,164,784Expenses 2020: $20,752,154Net Income 2020: -$587,3702020Revenue 2021: $20,220,623Expenses 2021: $19,901,457Net Income 2021: $319,1662021Revenue 2022: $9,961,492Expenses 2022: $12,803,344Net Income 2022: -$2,841,8522022

Highlighted filing

2019

Revenue$25,249,274
Expenses$24,773,576
Net Income$475,698
Open 2019 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2019 to Dec 31, 2019
Signed
Sep 30, 2020
Return Version
2019v5.1
Gross Receipts
$25,260,983
Mission and Program Overview

Mission

The international partnership for microbicides, inc. (ipm) was established in 2002 to accelerate the development and accessibility of microbicides to prevent the transmission of hiv. Its goal is to improve the efficiency to all efforts to deliver a safe and effective microbicide for women in developing countries as soon as possible.

To develop hiv prevention products and other sexual and reproductive health technologies for women, and to make them available and accessible where they are urgently needed.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$17,320,203$23,413,506▲ $6,093,303
Land, Buildings, and Equipment, Net$3,052,339$2,359,173▼ $693,166
Pledges and Grants Receivable$3,849,449$1,635,068▼ $2,214,381
Prepaid Expenses and Deferred Charges$359,504$444,058▲ $84,554
Savings and Temporary Cash Investments$205,248$232,752▲ $27,504
Accounts Receivable$51,457$29,225▼ $22,232
Other Notes and Loans Receivable, Net$0$0→ $0
Receivable From Disqualified Prsn$0$0→ $0
Receivables From Officers Etc$0$0→ $0
Investments Other Securities$0$0→ $0
Investments Program Related$0$0→ $0
Investments in Publicly Traded Securities$0$0→ $0
Intangible Assets$0$0→ $0
Inventories for Sale or Use$0$0→ $0
Loans From Officers Directors$0$0→ $0
Total Assets$24,838,200$28,113,782▲ $3,275,582
Other Assets Total$0$0→ $0
Liabilities
Deferred Revenue$9,435,517$12,327,264▲ $2,891,747
Accounts Payable and Accrued Expenses$2,643,705$2,722,118▲ $78,413
Other Liabilities$724,552$626,912▼ $97,640
Grants Payable$0$0→ $0
Mortgage Notes Payable Secured by Investment Property$0$0→ $0
Unsecured Notes Loans Payable$0$0→ $0
Escrow Account Liability$0$0→ $0
Tax Exempt Bond Liabilities$0$0→ $0
Total Liabilities$12,803,774$15,676,294▲ $2,872,520
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$12,034,426$12,437,488▲ $403,062
Net Assets With Donor Restrictions$0$0→ $0
Total Net Assets Fund Balance$12,034,426$12,437,488▲ $403,062
Total Liabilities and Net Assets / Fund Balance$24,838,200$28,113,782▲ $3,275,582

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$1,724,325$3,565,398$5,289,723
Other Land Buildings$91,322$1,075,578$1,166,900
Leasehold Improvements$543,526$334,806$878,332
Compensation and Service Providers
Top Officer Pay87th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Zeda RosenbergFounder AND CEOFT$483,171$122,713$605,884
Michael GoldrichPresident and COOFT$413,727$114,002$527,729
Brid DevlinEVP, Product DevelopmentFT$360,301$95,494$455,795
Patricia Mayer-BrennanEVP, Regulatory AffairsFT$336,701$96,756$433,457
Annalene NelEVP, Chief Medical OfficerFT$206,374$165,851$372,225
Kathleen FlynnChief Financial OfficerFT$274,260$66,953$341,213
Liza FolsteinSr. Director, Human ResourcesFT$241,857$86,090$327,947
Jeremy NuttallSr. Dir, Preclinical SciencesFT$220,801$80,691$301,492
Patrick SpenceSr. Dir, Chemistry & AnalyticaFT$212,142$89,274$301,416
Debleena SenguptaSr. Dir, Regulatory AffairsFT$201,700$63,585$265,285

Board Members and Trustees

NameTitle
Alex CoutinhoDirector
Ayo AjayiDirector
Florence HounDirector
Heidemarie Wieczorek-ZDirector
James McIntyreDirector
Lebogang MotsumiDirector
Mark MitchnickDirector
Maureen LubaDirector
Michael StevensDirector
Ndola PrataDirector
Pamela BarnesDirector
William CollierDirector

Highest Paid Contractors

ContractorServicesLocationCompensation
QPharmaManufacturing11325 Random Hills Road, Fairfax, VA 22030, Sw$2,909,593
OSIbeyond LLCIT Service-$355,141
SGS - Medisearch InternationalMedical Writing-$351,777
Quintiles Clindepharm Pty LtdClinical Monitoring11921 Rockville Pike Ste 210, Rockville, MD 20852, Sf$308,735
CGI Technologies and Solutions IncQuality AssuranceNOORDERLAAN, Antwerpen, 0, Be$296,872
Revenue and Support

Revenue Composition

Contributions and Grants
$24,039,020
Program Service Revenue
$0
Investment Income
$69,585
Other Revenue
$1,140,669
All Other Contributions
$1,628,360
Change in Net Assets
$475,698

Audited Revenue Reconciliation

Revenue per Audited Statements
$25,249,274
Revenue Not Reported on Form 990
$181,841
Total Revenue per Audited Statements
$25,431,115
Total Revenue per Form 990
$25,249,274
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$13,770,313
Salaries, Compensation, and Employee Benefits$11,003,263
Total Fundraising Expense$283,193
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$4,868,570$1,735,564$41,932$6,646,066
Current Officers, Directors, Trustees, and Key Employees$1,474,074$777,066$47,082$2,298,222
Other Employee Benefits$677,708$275,770$14,578$968,056
Office Expenses$699,361$97,960$4,399$801,720
Depreciation Depletion$738,718$50,477$0$789,195
Pension Plan Contributions$460,698$201,977$3,626$666,301
Travel$363,800$116,965$172$480,937
Payroll Taxes$292,848$127,933$3,837$424,618
Occupancy$348,415$47,351$0$395,766
Insurance$190,403$50,753$0$241,156
Fees for Services Legal$179,107$27,685$294$207,086
Fees for Services Accounting$27,448$163,222$0$190,670
Conferences and Meetings$82,196$61,271$24,376$167,843
All Other Expenses$9,797$41,823$-1$51,619
Other Expenses$0$1,980$0$1,980
Total Functional Expenses$20,218,115$4,272,268$283,193$24,773,576

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Audited Statements$25,028,054
Expenses per Audited Statements$24,773,576
Total Expenses per Form 990$24,773,576
Expenses Not Reported on Form 990$254,478
International Activity

International Summary

Offices
1
Employees
13
Spending
$4,124,653

International Compliance

Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Sub-Saharan AfricaProgram ServicesClinical110$3,314,987
Sub-Saharan AfricaProgram ServicesProgram Services03$752,979
Sub-Saharan AfricaProgram ServicesRegulatory & Qa Ser00$50,568
Sub-Saharan AfricaProgram ServicesProduct Development00$6,119
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$0
Fundraising Gross Income$0
Gaming Direct Expenses$0
Gaming Gross Income$0
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Insider Transactions and Loans

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$0$0→ $0
Receivables from Disqualified Persons$0$0→ $0
Receivables from Officers, Directors, Trustees, and Key Employees$0$0→ $0
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Deferred Rent$626,912
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

FORM 990, Part VI, Section B, Line 11B:

“Draft version is made available electronically to the finance committee before submission to the irs.”

FORM 990, Part VI, Section B, Line 12C:

“Employees are required to complete a confidentiality agreement with the organization annually. The employee discloses any areas of potential conflict of interest and agrees to notify the appropriate individuals of any potential occurrences.”

FORM 990, Part VI, Section B, Line 15B:

“The salary of the ceo is determined by referencing industry data to identify compensation level based on responsibilities, size of organization, and funding levels. Once the data is accumulated, the information is then presented to the finance chairperson and committee for review and approval of the board of directors. Upon approval, the approved salary is sent to the hr department by a member of the board of directors and/or coo for implementation. All chief level salaries are subject to the same procedures as the ceo salary review process. Compensation level recommendations are presented to the finance chairperson and committee for review and approval of the board of directors. Once the compensation levels has been approved, a member of the board of directors and/or ceo and/or coo submits these approvals to hr for implementation.”

FORM 990, Part VI, SECTION C, Line 19:

“The organization's governing documents, conflict of interest policy and financial statements are made available to the public upon request. The financial statements are also part of the organization's annual report which is distributed to its donors and available to the public upon request.”

Filing and Contact Details

Filer

Filer Name
International Partnership for Microbicides
EIN
01-0741733
In Care Of
% ZEDA F ROSENBERG
Phone
3016082221
Address
8405 COLESVILLE ROAD Suite 600, SILVER SPRING, MD 20910

Signing Officer

Name
Kathleen Flynn
Title
CFO
Phone
3016082221
Signed
2020-09-30
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Zeda F Rosenberg
Formed
2002
Legal Domicile
Nc
Voting Board Members
12
Independent Board Members
12
Employees
42
Volunteers
12

Preparer

Firm
Bdo USA Llp
Address
8401 GREENSBORO DRIVE 800, MCLEAN, VA 22102
Preparer
Marc Berger
Phone
7038930600
Supplemental Narrative

Additional Explanations

FORM 990, Part III - Program Service, LINE 4D:

“PROGRAM SUPPORT & ACCESS: In 2019, IPM continued to build awareness globally about microbicides and create a favorable environment in support of microbicide product development. This is achieved by informing, educating, and building support for IPM's work through communication materials, advocacy and direct stakeholder engagement. In conjunction with these efforts, IPM also continued work to ensure that the monthly dapivirine ring, if approved by regulators, can quickly reach the women in developing countries, who face the highest risk of HIV. This work includes partnering with a global network of organizations, including government, pharmaceutical, health services, civil society and academic sectors, to strategically plan for affordable access to the dapivirine ring. EXPENSES $2,703,503 INCLUDING GRANTS OF $0 REVENUE $0”

FORM 990, PART XI, LINE 9:

“Foreign currency loss -72,638”

FORM 990, PART XII, LINE 2C:

“Organization oversight: the process for overseeing the audit of the financial statements and selection of an independent accountant that audited the financial statements has been consistent with prior years.”

Financial Statement Notes

PART X, LINE 2:

“IPM is generally exempt from federal income taxes under the provisions of Section 501(c)(3) of the Internal Revenue Code. In addition, IPM qualifies for charitable contributions deductions and has been classified as an organization that is not a private foundation. Income which is not related to exempt purposes, less applicable deductions, is subject to federal and state income taxes. The Organization recorded a tax liability for unrelated business income of $0 and $2,854 for the years ended December 31, 2019 and 2018. IPM is still open to examination by U.S. federal or state tax authorities on its tax returns submitted 2016 and thereafter. A tax positon is recognized as a benefit only if it is "more likely than not" that the tax position taken would be sustained in a tax examination, presuming that a tax examination will occur. Management believes it has no material uncertain tax positions and, accordingly, has not recognized any liability or penalties and interest for unrecognized tax benefits. The Organization recognizes interest and/or penalties related to uncertain tax positions, if any, as income tax expense in the accompanying consolidated statement of activities. No interest and/or penalties were recorded for the years ended December 31, 2019 and 2018 related to uncertain tax positions.”

PART XI, LINE 2D:

“Foreign currency loss (72,638) revenue of affiliates in consolidated financials 4,478 ----------- total (68,159)”

PART XII, LINE 2D:

“Expenses of affiliates in consolidated financials $4,478”

Raw XML AppendixShowing 400 of 996 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt02643705
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt02722118
IRS990/AccountsReceivableGrp/BOYAmt051457
IRS990/AccountsReceivableGrp/EOYAmt029225
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0TO DEVELOP HIV PREVENTION PRODUCTS AND OTHER SEXUAL AND REPRODUCTIVE HEALTH TECHNOLOGIES FOR WOMEN, AND TO MAKE THEM AVAILABLE AND ACCESSIBLE WHERE THEY ARE URGENTLY NEEDED.
IRS990/AdvertisingGrp/TotalAmt00
IRS990/AllOtherContributionsAmt01628360
IRS990/AllOtherExpensesGrp/FundraisingAmt0-1
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt041823
IRS990/AllOtherExpensesGrp/ProgramServicesAmt09797
IRS990/AllOtherExpensesGrp/TotalAmt051619
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/AuditCommitteeInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BenefitsToMembersGrp/TotalAmt00
IRS990/BooksInCareOfDetail/PersonNm0ZEDA F ROSENBERG
IRS990/BooksInCareOfDetail/PhoneNum03016082221
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt08405 COLESVILLE ROAD STE 600
IRS990/BooksInCareOfDetail/USAddress/CityNm0SILVER SPRING
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MD
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020910
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt017320203
IRS990/CashNonInterestBearingGrp/EOYAmt023413506
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CntrctRcvdGreaterThan100KCnt030
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt047082
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0777066
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt01474074
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt02298222
IRS990/CompDisqualPersonsGrp/TotalAmt00
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0true
IRS990/CompensationProcessOtherInd0true
IRS990/ConferencesMeetingsGrp/FundraisingAmt024376
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt061271
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt082196
IRS990/ConferencesMeetingsGrp/TotalAmt0167843
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0true
IRS990/ContractorCompensationGrp/CompensationAmt02909593
IRS990/ContractorCompensationGrp/CompensationAmt1308735
IRS990/ContractorCompensationGrp/CompensationAmt2296872
IRS990/ContractorCompensationGrp/CompensationAmt3355141
IRS990/ContractorCompensationGrp/CompensationAmt4351777
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt0BOX 590 SE-201 25
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt11011 PRETORIUS AVENUE SOUTH
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt2NOORDERLAAN
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm0MALMO
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm1LYTTELTON MANOR
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm2ANTWERPEN
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd0SW
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd1SF
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd2BE
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ProvinceOrStateNm00
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ProvinceOrStateNm1IRENE
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ProvinceOrStateNm20
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt011325 Random Hills Road
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt111921 Rockville Pike Ste 210
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0FAIRFAX
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1ROCKVILLE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0VA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1MD
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd022030
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd120852
IRS990/ContractorCompensationGrp/ContractorName/PersonNm0QPharma
IRS990/ContractorCompensationGrp/ContractorName/PersonNm1Quintiles Clindepharm Pty Ltd
IRS990/ContractorCompensationGrp/ContractorName/PersonNm2CGI Technologies and Solutions Inc
IRS990/ContractorCompensationGrp/ContractorName/PersonNm3OSIbeyond LLC
IRS990/ContractorCompensationGrp/ContractorName/PersonNm4SGS - Medisearch International
IRS990/ContractorCompensationGrp/ServicesDesc0Manufacturing
IRS990/ContractorCompensationGrp/ServicesDesc1Clinical Monitoring
IRS990/ContractorCompensationGrp/ServicesDesc2Quality Assurance
IRS990/ContractorCompensationGrp/ServicesDesc3IT Service
IRS990/ContractorCompensationGrp/ServicesDesc4MEDICAL WRITING
IRS990/CostOfGoodsSoldAmt00
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt024039020
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt069585
IRS990/CYOtherExpensesAmt013770313
IRS990/CYOtherRevenueAmt01140669
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0475698
IRS990/CYSalariesCompEmpBnftPaidAmt011003263
IRS990/CYTotalExpensesAmt024773576
IRS990/CYTotalFundraisingExpenseAmt0283193
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt025249274
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DeferredRevenueGrp/BOYAmt09435517
IRS990/DeferredRevenueGrp/EOYAmt012327264
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/FundraisingAmt00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt050477
IRS990/DepreciationDepletionGrp/ProgramServicesAmt0738718
IRS990/DepreciationDepletionGrp/TotalAmt0789195
IRS990/Desc0IPM's clinical affairs department is responsible for quality control and compliance, medical safety, clinical operations, biometrics, public affairs, community public affairs and socio-behavioral sciences for IPM's clinical trials. Key clinical trials initiated or ongoing in 2019 included: - Clinical Trials of the monthly dapivirine vaginal ring The dapivirine ring extended access and monitoring study (DREAM study/ IPM 032) initiated in July 2016, DREAM was a Phase IIIb open-label study providing the dapivirine ring to women who participated in the former Phase III dapivirine ring trial in Africa (The Ring Study/ IPM 027) who tested HIV-negative and were not pregnant. The study collected additional safety data and information on how women use the ring. As of January 2019, all DREAM participants were exited from the trial. The results from the study were announced in 2019 and showed increases in participant use of the monthly dapivirine ring and modelling data suggest greater HIV-1 risk reduction by over 50% compared to the Phase III clinical trials. Although these modelling results are limited due to the lack of a placebo comparison group, they indicate an encouraging trend IPM hopes to see continue if the ring receives regulatory approval and rolled out. In 2019, IPMs clinical trial partner, the United States (US) National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), initiated the "Reversing the Epidemic in Africa with Choices in HIV prevention" study (REACH/MTN-034). The trial is designed to collect data on the safety and acceptability of the monthly dapivirine ring versus daily oral PrEP (Truvada) in HIV-uninfected adolescent females between the ages of 16-21 years old. This trial will remain ongoing through 2021. - Clinical trial of IPM's three-month dapivirine ring Building on the promise of IPM's monthly dapivirine ring, IPM developed the three-month dapivirine ring, which is designed to increase convenience and reduce annual costs as compared to the monthly dapivirine ring. The phase I trial, which was conducted by the MTN in collaboration with IPM, will inform the design of future clinical studies and a possible regulatory strategy for this product. The trial initiated in December 2017 and the last participant visit occurred in January 2019. Data analysis and results are expected to be complete in 2020. - Clinical trials of the dapivirine-contraceptive vaginal ring, a multipurpose prevention technology (MPT) The three-month dapivirine-contraceptive ring is designed to provide slow and simultaneous release of both the antiretroviral (ARV) drug dapivirine to prevent HIV and the contraceptive hormone levonorgestrel to prevent unintended pregnancy. The first safety study of IPM's dapivirine-contraceptive ring began in April 2017 at two sites in the United States, and is being led by IPM's partner, the US National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN). Data analysis/study report development was ongoing in 2019 for this study; a final clinical study report is expected in 2020. A second phase I clinical trial of the MPT ring was conducted by the Contraceptive Clinical Trials Network (CCTN) from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in collaboration with the MTN. The trial began in July 2018 and participant visits completed in August 2019. Data analysis and results are expected to be complete in 2020.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt00
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt00
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt042
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/EscrowAccountLiabilityGrp/BOYAmt00
IRS990/EscrowAccountLiabilityGrp/EOYAmt00
IRS990/ExpenseAmt05150730
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditPerformedInd0true
IRS990/FederalGrantAuditRequiredInd0true
IRS990/FeesForServicesAccountingGrp/FundraisingAmt00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0163222
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt027448
IRS990/FeesForServicesAccountingGrp/TotalAmt0190670
IRS990/FeesForServicesLegalGrp/FundraisingAmt0294
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt027685
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0179107
IRS990/FeesForServicesLegalGrp/TotalAmt0207086
IRS990/FeesForServicesLobbyingGrp/TotalAmt00
IRS990/FeesForServicesManagementGrp/TotalAmt00
IRS990/FeesForServicesOtherGrp/TotalAmt00
IRS990/FeesForServicesProfFundraising/TotalAmt00
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt00
IRS990/ForeignActivitiesInd0true
IRS990/ForeignCountryCd0SF
IRS990/ForeignCountryCd1UK
IRS990/ForeignFinancialAccountInd0true
IRS990/ForeignGrantsGrp/TotalAmt00
IRS990/ForeignOfficeInd0true
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt00.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt20.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt30.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt40.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt50.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt60.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt70.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt80.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt90.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt100.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt110.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt120.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt130.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt140.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt150.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt160.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt170.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt180.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt190.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt200.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt210.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt140.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt240.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt340.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt440.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt540.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt640.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt740.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt840.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt940.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt101.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt111.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt121.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt131.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt141.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt151.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt161.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt171.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt181.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt191.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt201.0
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt211.0
IRS990/Form990PartVIISectionAGrp/FormerOfcrDirectorTrusteeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd12X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt072890
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt189717
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt278909
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt374580
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt430624
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt554066
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt673630
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt769832
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt877703
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt953080
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt120
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt130
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt140
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt150
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt160
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt170
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt180
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt190
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt200
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt210
IRS990/Form990PartVIISectionAGrp/PersonNm0Zeda Rosenberg
IRS990/Form990PartVIISectionAGrp/PersonNm1Michael Goldrich
IRS990/Form990PartVIISectionAGrp/PersonNm2Brid Devlin
IRS990/Form990PartVIISectionAGrp/PersonNm3Patricia Mayer-Brennan
IRS990/Form990PartVIISectionAGrp/PersonNm4Annalene Nel
IRS990/Form990PartVIISectionAGrp/PersonNm5Kathleen Flynn
IRS990/Form990PartVIISectionAGrp/PersonNm6Liza Folstein
IRS990/Form990PartVIISectionAGrp/PersonNm7Jeremy Nuttall
IRS990/Form990PartVIISectionAGrp/PersonNm8Patrick Spence
IRS990/Form990PartVIISectionAGrp/PersonNm9Debleena Sengupta
IRS990/Form990PartVIISectionAGrp/PersonNm10Heidemarie Wieczorek-Z
IRS990/Form990PartVIISectionAGrp/PersonNm11James McIntyre
IRS990/Form990PartVIISectionAGrp/PersonNm12Lebogang Motsumi
IRS990/Form990PartVIISectionAGrp/PersonNm13Michael Stevens
IRS990/Form990PartVIISectionAGrp/PersonNm14Ayo Ajayi
IRS990/Form990PartVIISectionAGrp/PersonNm15Ndola Prata
IRS990/Form990PartVIISectionAGrp/PersonNm16Pamela Barnes
IRS990/Form990PartVIISectionAGrp/PersonNm17Florence Houn
IRS990/Form990PartVIISectionAGrp/PersonNm18Alex Coutinho
IRS990/Form990PartVIISectionAGrp/PersonNm19Maureen Luba
IRS990/Form990PartVIISectionAGrp/PersonNm20William Collier
IRS990/Form990PartVIISectionAGrp/PersonNm21Mark Mitchnick
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0532994
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt1438012
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt2376886
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt3358877
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt4341601
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt5287147
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt6254317
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt7231660
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt8223713
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9212205
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt180
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt190
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt200
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt210
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt180
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt190
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt200
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt210
IRS990/Form990PartVIISectionAGrp/TitleTxt0Founder AND CEO
IRS990/Form990PartVIISectionAGrp/TitleTxt1President and COO
IRS990/Form990PartVIISectionAGrp/TitleTxt2EVP, Product Development
IRS990/Form990PartVIISectionAGrp/TitleTxt3EVP, Regulatory Affairs
IRS990/Form990PartVIISectionAGrp/TitleTxt4EVP, Chief Medical Officer
IRS990/Form990PartVIISectionAGrp/TitleTxt5Chief Financial Officer
IRS990/Form990PartVIISectionAGrp/TitleTxt6Sr. Director, Human Resources
IRS990/Form990PartVIISectionAGrp/TitleTxt7Sr. Dir, Preclinical Sciences
IRS990/Form990PartVIISectionAGrp/TitleTxt8Sr. Dir, Chemistry & Analytica
IRS990/Form990PartVIISectionAGrp/TitleTxt9Sr. Dir, Regulatory Affairs
IRS990/Form990PartVIISectionAGrp/TitleTxt10Director
IRS990/Form990PartVIISectionAGrp/TitleTxt11Director
IRS990/Form990PartVIISectionAGrp/TitleTxt12Director
IRS990/Form990PartVIISectionAGrp/TitleTxt13Director
IRS990/Form990PartVIISectionAGrp/TitleTxt14Director
IRS990/Form990PartVIISectionAGrp/TitleTxt15Director
IRS990/Form990PartVIISectionAGrp/TitleTxt16Director
IRS990/Form990PartVIISectionAGrp/TitleTxt17Director
IRS990/Form990PartVIISectionAGrp/TitleTxt18Director
IRS990/Form990PartVIISectionAGrp/TitleTxt19Director
IRS990/Form990PartVIISectionAGrp/TitleTxt20Director
IRS990/Form990PartVIISectionAGrp/TitleTxt21Director
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr02002
IRS990/FormerOfcrEmployeesListedInd0true
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd0true
IRS990/FundraisingActivitiesInd0false
IRS990/FundraisingDirectExpensesAmt00
IRS990/FundraisingGrossIncomeAmt00
IRS990/GainOrLossGrp/OtherAmt0-3096
IRS990/GamingActivitiesInd0false
IRS990/GamingDirectExpensesAmt00
IRS990/GamingGrossIncomeAmt00
IRS990/GoverningBodyVotingMembersCnt012
IRS990/GovernmentGrantsAmt022410660
IRS990/GrantAmt00
IRS990/GrantsPayableGrp/BOYAmt00
IRS990/GrantsPayableGrp/EOYAmt00
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt00
IRS990/GrantsToDomesticOrgsGrp/TotalAmt00
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossAmountSalesAssetsGrp/OtherAmt08613
IRS990/GrossReceiptsAmt025260983
IRS990/GrossSalesOfInventoryAmt00
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0true
IRS990/IncmFromInvestBondProceedsGrp/TotalRevenueColumnAmt00
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt012
IRS990/IndivRcvdGreaterThan100KCnt035
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartVInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/TotalAmt00
IRS990/InsuranceGrp/FundraisingAmt00
IRS990/InsuranceGrp/ManagementAndGeneralAmt050753
IRS990/InsuranceGrp/ProgramServicesAmt0190403
IRS990/InsuranceGrp/TotalAmt0241156
IRS990/IntangibleAssetsGrp/BOYAmt00
IRS990/IntangibleAssetsGrp/EOYAmt00
IRS990/InterestGrp/TotalAmt00
IRS990/InventoriesForSaleOrUseGrp/BOYAmt00
IRS990/InventoriesForSaleOrUseGrp/EOYAmt00
IRS990/InvestmentIncomeGrp/ExclusionAmt072681
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt072681
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsOtherSecuritiesGrp/BOYAmt00
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt00
IRS990/InvestmentsProgramRelatedGrp/BOYAmt00
IRS990/InvestmentsProgramRelatedGrp/EOYAmt00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt00
IRS990/InvestmentsPubTradedSecGrp/EOYAmt00
IRS990/IRPDocumentCnt030
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt04975783
IRS990/LandBldgEquipBasisNetGrp/BOYAmt03052339
IRS990/LandBldgEquipBasisNetGrp/EOYAmt02359173
IRS990/LandBldgEquipCostOrOtherBssAmt07334956
IRS990/LegalDomicileStateCd0NC
IRS990/LessCostOthBasisSalesExpnssGrp/OtherAmt011709
IRS990/LoanOutstandingInd0false
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt00
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt00
IRS990/LobbyingActivitiesInd0true
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0TO DEVELOP HIV PREVENTION PRODUCTS AND OTHER SEXUAL AND REPRODUCTIVE HEALTH TECHNOLOGIES FOR WOMEN, AND TO MAKE THEM AVAILABLE AND ACCESSIBLE WHERE THEY ARE URGENTLY NEEDED.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0true
IRS990/MortgNotesPyblScrdInvstPropGrp/BOYAmt00

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2019 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$28,113,782
Liabilities
$15,676,294
Net assets
$12,437,488
Revenue
$25,249,274
Expenses
$24,773,576
Net income
$475,698
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.00$0.00$0.00$9.96$12.8$2.84
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$16.2$4.39$11.8$20.2$19.9$0.32
2020Detailed filing. Detailed filing data is available for this year.$23.5$11.9$11.6$20.2$20.8$0.59
2019Detailed filing. Detailed filing data is available for this year.$28.1$15.7$12.4$25.2$24.8$0.48
2018Facts available. Structured filing facts are available, but richer extracted sections are limited.$24.8$12.8$12.0$25.2$26.3$1.13
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$23.0$9.79$13.3$35.7$36.8$1.08
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$20.1$5.53$14.5$36.0$33.8$2.19
2015Import issue. A filing source exists for this year, but detailed import did not complete cleanly.$23.2$10.2$13.0$33.0$33.2$0.22
2014Detailed filing. Detailed filing data is available for this year.$28.9$14.1$14.8$31.6$32.2$0.69
2013Detailed filing. Detailed filing data is available for this year.$40.5$23.4$17.1$32.8$33.4$0.66
2012Summary only. Only limited summary data is available for this year.$42.0$22.7$19.3$31.7$31.0$0.64
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$52.6$31.5$21.1$37.7
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$81.5$58.2$23.3$56.3